Detailed information for compound 1371855
Basic information
Technical information
- TDR Targets ID: 1371855
- Name: N-pentan-2-yl-1-phenylsulfonylpiperidine-4-ca rboxamide
- MW: 338.465 | Formula: C17H26N2O3S
-
H donors: 1
H acceptors: 3
LogP: 2.53
Rotable bonds: 7
Rule of 5 violations (Lipinski): 1 - SMILES: CCCC(NC(=O)C1CCN(CC1)S(=O)(=O)c1ccccc1)C
- InChi: 1S/C17H26N2O3S/c1-3-7-14(2)18-17(20)15-10-12-19(13-11-15)23(21,22)16-8-5-4-6-9-16/h4-6,8-9,14-15H,3,7,10-13H2,1-2H3,(H,18,20)
- InChiKey: NKDBUUVZVPDJTQ-UHFFFAOYSA-N
Network
Hover on a compound node to display the structore
Synonyms
- N-(1-methylbutyl)-1-phenylsulfonyl-piperidine-4-carboxamide
- N-(1-methylbutyl)-1-phenylsulfonyl-4-piperidinecarboxamide
- N-(1-methylbutyl)-1-phenylsulfonyl-isonipecotamide
- N-pentan-2-yl-1-phenylsulfonyl-piperidine-4-carboxamide
- MLS000124098
- 1-Benzenesulfonyl-piperidine-4-carboxylic acid (1-methyl-butyl)-amide
- BAS 07563459
- SMR000124598
Targets
Known targets for this compound
| Species | Target name | Source | Bibliographic reference |
|---|---|---|---|
| Rattus norvegicus | Inositol monophosphatase 1 | Starlite/ChEMBL | No references |
Predicted pathogen targets for this compound
By orthology
By sequence similarity to non orthologous known druggable targets
Obtained from network model
Ranking Plot
Putative Targets List
| Species | Potential target | Raw | Global | Species |
|---|---|---|---|---|
| Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.0045 | 0.0082 | 0.5 |
| Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.0082 | 0.5 |
| Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0045 | 0.0082 | 0.5 |
| Schistosoma mansoni | inositol monophosphatase | 0.0045 | 0.0082 | 0.5 |
| Entamoeba histolytica | myo-inositol monophosphatase, putative | 0.0045 | 0.0082 | 0.5 |
| Echinococcus granulosus | inositol monophosphatase 1 | 0.0045 | 0.0082 | 0.5 |
| Trypanosoma brucei | inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.0082 | 0.5 |
| Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0045 | 0.0082 | 0.5 |
| Echinococcus multilocularis | inositol monophosphatase 1 | 0.0045 | 0.0082 | 0.5 |
| Mycobacterium tuberculosis | Naphthoate synthase MenB (dihydroxynaphthoic acid synthetase) (DHNA synthetase) | 0.0612 | 1 | 1 |
| Brugia malayi | Inositol-1 | 0.0045 | 0.0082 | 0.5 |
| Schistosoma mansoni | inositol monophosphatase | 0.0045 | 0.0082 | 0.5 |
| Mycobacterium ulcerans | naphthoate synthase | 0.0612 | 1 | 1 |
| Leishmania major | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.0082 | 0.5 |
| Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0045 | 0.0082 | 0.5 |
| Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0045 | 0.0082 | 0.5 |
| Loa Loa (eye worm) | inositol-1 | 0.0045 | 0.0082 | 0.5 |
| Trichomonas vaginalis | inositol monophosphatase, putative | 0.0045 | 0.0082 | 0.5 |
Activities
| Activity type | Activity value | Assay description | Source | Reference |
|---|---|---|---|---|
| Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ] | ChEMBL. | No reference |
| Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Phenotypes
Whole-cell/tissue/organism interactions
| Species name | Source | Reference | Is orphan |
|---|---|---|---|
| Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
Annotated phenotypes:
We have no manually annotated phenotypes for this drug.
What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by
drugs, or by genetic manipulation of cells (e.g. gene knockouts or
knockdowns) is manually curated from the literature. These
descriptions help to describe the potential of the target for drug
development. If no information is available for this gene or if the
information is incomplete, this may mean that i) the papers
containing this information either appeared after the curation
effort for this organism was carried out or they were inadvertently
missed by curators; or that ii) the curation effort for this
organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.
External resources for this compound
- ChEMBL: CHEMBL1504015
Bibliographic References
No literature references available for this target.
If you have references for this compound, please enter them in a user comment (below) or Contact us.